Company: NCEL
Filing Date: 2025-10-24
Form Type: POS AM
Source: 0001213900-25-102149
Chunk: 3

Company: NewcelX Ltd.
Filing Date: 2025-10-24
Form: POS AM
Chunk 3
---
i) lowest
sale price on the applicable date of the purchase of such Common Shares and (ii) the volume average weighted price (the “VWAP”),
over the applicable VWAP Purchase Period (as defined in the Purchase Agreement) on the applicable date of the purchase of such Common
Shares.

The Selling Shareholder may
sell the Common Shares included in this prospectus in a number of different ways and at varying prices. We provide more information about
how the Selling Shareholder may sell the shares in the section entitled “Plan of Distribution”. The Selling Shareholder
is an “underwriter” within the meaning of Section 2(a)(11) of the Securities Act of 1933, as amended (the “Securities
Act”).

The Selling Shareholder will
pay all brokerage fees and commissions and similar expenses in connection with the offer and sale of the Common Shares by the Selling
Shareholder pursuant to this prospectus. We will pay the expenses (except brokerage fees and commissions and similar expenses) incurred
to register under the Securities Act the offer and sale of the Common Shares included in this prospectus by the Selling Shareholder. See
“Plan of Distribution”.

Our Common Shares are
listed on the Nasdaq Capital Market (“Nasdaq”), under the symbol “NLSP”. On October 22, 2025, the last reported
sale price of our Common Shares on Nasdaq was $1.59 per share.

Investing in our securities involves a high degree of risk. See “Risk Factors” beginning on page 13 of this prospectus.

Neither the Securities and Exchange Commission (the “SEC”), nor any state or other foreign securities commission has approved nor disapproved these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

<div align='center'>The date of this prospectus is , 2025

TABLE OF CONTENTS</div>

|                                                      |     | Page |
| Prospectus Summary                                   |     |    1 |
| Risk Factors                                         |     |   13 |
| Cautionary Note Regarding Forward-Looking Statements |     |   15 |
| Use of Proceeds                                      |     |   17 |
| Dividend Policy                                      |     |   17 |
| Capitalization                                       |     |   17 |
| Description of Share Capital                         |     |   18 |
| Selling Shareholder                                  |     |   34 |
| Plan of Distribution                                 |     |